JP2002516900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002516900A5 JP2002516900A5 JP2000552085A JP2000552085A JP2002516900A5 JP 2002516900 A5 JP2002516900 A5 JP 2002516900A5 JP 2000552085 A JP2000552085 A JP 2000552085A JP 2000552085 A JP2000552085 A JP 2000552085A JP 2002516900 A5 JP2002516900 A5 JP 2002516900A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solvate
- pharmaceutically acceptable
- preparing
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 29
- 239000012453 solvate Substances 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 230000002265 prevention Effects 0.000 claims 6
- 125000006239 protecting group Chemical group 0.000 claims 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 5
- 206010022489 Insulin Resistance Diseases 0.000 claims 4
- 230000003301 hydrolyzing effect Effects 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000001421 hyperglycemia Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801992A SE9801992D0 (sv) | 1998-06-04 | 1998-06-04 | New 3-aryl-2-hydroxypropionic acid derivative I |
| SE9801992-0 | 1998-06-04 | ||
| PCT/SE1999/000941 WO1999062872A1 (en) | 1998-06-04 | 1999-05-31 | New 3-aryl-2-hydroxypropionic acid derivative (i) |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003273428A Division JP2004043480A (ja) | 1998-06-04 | 2003-07-11 | 新規な３−アリール−２−ヒドロキシプロピオン酸誘導体ｉの中間体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002516900A JP2002516900A (ja) | 2002-06-11 |
| JP3554539B2 JP3554539B2 (ja) | 2004-08-18 |
| JP2002516900A5 true JP2002516900A5 (https=) | 2005-04-28 |
Family
ID=20411587
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000552085A Expired - Fee Related JP3554539B2 (ja) | 1998-06-04 | 1999-05-31 | 新規な３−アリール−２−ヒドロキシプロピオン酸誘導体ｉ |
| JP2003273428A Withdrawn JP2004043480A (ja) | 1998-06-04 | 2003-07-11 | 新規な３−アリール−２−ヒドロキシプロピオン酸誘導体ｉの中間体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003273428A Withdrawn JP2004043480A (ja) | 1998-06-04 | 2003-07-11 | 新規な３−アリール−２−ヒドロキシプロピオン酸誘導体ｉの中間体 |
Country Status (39)
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8702758D0 (en) * | 1987-02-06 | 1987-03-11 | Wellcome Found | Treatment of disease |
| EP0996459B1 (en) | 1997-01-07 | 2005-09-21 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for the reduction of food intake |
| CN1280574A (zh) * | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物 |
| SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| GB0001662D0 (en) * | 1999-02-06 | 2000-03-15 | Zeneca Ltd | Pharmaceutical compositions |
| US7084177B2 (en) | 1999-12-03 | 2006-08-01 | Astrazeneca Ab | Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid |
| DK1237855T3 (da) * | 1999-12-03 | 2004-06-14 | Astrazeneca Ab | Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre |
| SE9904421D0 (sv) | 1999-12-03 | 1999-12-03 | Astra Ab | New compounds |
| SE9904415D0 (sv) * | 1999-12-03 | 1999-12-03 | Astra Ab | New process |
| TW574193B (en) | 1999-12-03 | 2004-02-01 | Astrazeneca Ab | Novel phenalkyloxy-phenyl derivatives, pharmaceutical composition containing the same and their uses |
| CA2396157A1 (en) * | 2000-01-10 | 2001-07-19 | Amylin Pharmaceuticals, Inc. | Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| US6559335B2 (en) | 2000-09-22 | 2003-05-06 | Dr. Reddy's Laboratories Limited | Process for the preparation of 3-aryl-2-hydroxy propanoic acid |
| ATE341343T1 (de) | 2000-12-26 | 2006-10-15 | Sankyo Co | Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel |
| SE0101386D0 (sv) | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | New compounds |
| SE0101982D0 (sv) * | 2001-06-01 | 2001-06-01 | Astrazeneca Ab | Pharmaceutical combination |
| NZ529815A (en) * | 2001-06-01 | 2005-11-25 | Astrazeneca Ab | Process for the preparation 3-aryl-2-hydroxypropionic acid derivative |
| SE0101981D0 (sv) * | 2001-06-01 | 2001-06-01 | Astrazeneca Ab | Pharmaceutical combination |
| SE0101980D0 (sv) * | 2001-06-01 | 2001-06-01 | Astrazeneca Ab | Pharmaceutical combination |
| SE0101978D0 (sv) | 2001-06-01 | 2001-06-01 | Astrazeneca Ab | New compounds |
| MXPA03011201A (es) | 2001-06-07 | 2004-02-26 | Lilly Co Eli | Moduladores de receptores activados por proliferadores de persoxisomas. |
| MXPA03011558A (es) * | 2001-06-12 | 2004-03-26 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de desordenes metabolicos. |
| UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
| SE0104333D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0229931D0 (en) * | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| JP2005518408A (ja) | 2001-12-29 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | 異常脂肪血症を治療するための、ｇｌｐ−１化合物と他の薬物との組み合わせ使用 |
| SE0201005D0 (sv) * | 2002-04-02 | 2002-04-02 | Astrazeneca Ab | New Process |
| US20050119314A1 (en) * | 2002-04-05 | 2005-06-02 | Sankyo Company, Limited | Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent |
| SE0201936D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| PL375074A1 (en) * | 2002-06-20 | 2005-11-14 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| SE0201937D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | Therapeutic agents |
| US7351858B2 (en) * | 2002-06-20 | 2008-04-01 | Astrazeneca Ab | Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| US7232828B2 (en) | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| DE10308353A1 (de) | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10308352A1 (de) | 2003-02-27 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE10308351A1 (de) | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU2004266204A1 (en) * | 2003-06-06 | 2005-03-03 | Cadila Healthcare Limited | Process for preparing 3-aryl-2-hydroxy propanoic acid derivatives without resolution |
| GB0314131D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314078D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314075D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314130D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0314260D0 (en) * | 2003-06-19 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| CN1882327A (zh) | 2003-11-19 | 2006-12-20 | 症变治疗公司 | 含磷的新的拟甲状腺素药 |
| US20070142472A1 (en) * | 2003-11-27 | 2007-06-21 | Tohru Yokozawa | Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids |
| EP1586573B1 (en) | 2004-04-01 | 2007-02-07 | Sanofi-Aventis Deutschland GmbH | Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
| EP1735287A1 (en) | 2004-04-03 | 2006-12-27 | Astrazeneca AB | Therapeutic agents |
| FR2872159B1 (fr) * | 2004-06-28 | 2007-10-05 | Merck Sante Soc Par Actions Si | Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete |
| TW200608967A (en) | 2004-07-29 | 2006-03-16 | Sankyo Co | Pharmaceutical compositions containing with diabetic agent |
| AU2006222060B2 (en) * | 2005-03-08 | 2011-09-01 | Takeda Gmbh | Roflumilast for the treatment of diabetes mellitus |
| DE102005026762A1 (de) | 2005-06-09 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
| AU2007274598A1 (en) * | 2006-07-21 | 2008-01-24 | Lupin Limited | Antidiabetic azabicyclo [3. 1. 0] hexan compounds |
| KR100958831B1 (ko) * | 2006-09-19 | 2010-05-24 | 주식회사유한양행 | 헤테로아릴피리미딘 유도체, 이들의 제조방법, 및 이들을포함하는 조성물 |
| US20090082441A1 (en) * | 2007-09-25 | 2009-03-26 | Protia, Llc | Deuterium-enriched tesaglitazar |
| US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
| PL3400944T3 (pl) | 2010-11-04 | 2020-11-16 | Albireo Ab | Inhibitory ibat w leczeniu chorób wątroby |
| JP6097695B2 (ja) | 2010-11-08 | 2017-03-15 | アルビレオ アクチエボラグ | Ｉｂａｔ阻害剤および胆汁酸結合剤を含む薬学的組み合わせ |
| WO2013041621A1 (de) | 2011-09-20 | 2013-03-28 | Basf Se | Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung |
| PL2978748T3 (pl) * | 2013-03-27 | 2017-09-29 | Pfizer Ireland Pharmaceuticals | Sposób i związki pośrednie do wytwarzania pregabaliny |
| WO2015013187A1 (en) * | 2013-07-22 | 2015-01-29 | Metabolic Solutions Development Co., Llc | Ppar-sparing compounds for the treatment of metabolic diseases |
| EP4615433A1 (en) | 2022-11-08 | 2025-09-17 | Genfit | Ppar-alpha/gamma agonist for use in the treatment of liver failure |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4114417A (en) * | 1977-06-27 | 1978-09-19 | Schmelzer Corporation | Method and apparatus for making metal parts |
| US4479005A (en) * | 1982-12-16 | 1984-10-23 | The Dow Chemical Company | Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids |
| FR2653119B1 (fr) | 1989-10-18 | 1994-08-05 | Lipha | Nouveaux aryloxy alcoyl benzenes, leurs procedes de preparation et les compositions pharmaceutiques en renfermant. |
| US5068345A (en) * | 1989-10-30 | 1991-11-26 | Eastman Kodak Company | Oxazolidinone aldol adduct |
| US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| GB9114948D0 (en) * | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline intermediates |
| CA2139442A1 (en) * | 1992-07-03 | 1994-01-20 | David Haigh | Heterocyclic compounds as pharmaceutical |
| US5232945A (en) | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
| US5648541A (en) * | 1995-09-28 | 1997-07-15 | Nps Pharmaceuticals, Inc. | Chiral reductions of imines leading to the syntheses of optically active amines |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| DK0916651T3 (da) * | 1996-04-04 | 2003-12-01 | Sankyo Co | Phenylalkylcarboxylsyrederivater |
| AU749505B2 (en) * | 1997-10-27 | 2002-06-27 | Dr. Reddy's Laboratories Limited | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| SE9801990D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl propionic acid derivatives and analogs |
| MA26634A1 (fr) * | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
-
1998
- 1998-06-04 SE SE9801992A patent/SE9801992D0/xx unknown
-
1999
- 1999-05-20 MA MA25592A patent/MA26635A1/fr unknown
- 1999-05-23 DZ DZ990100A patent/DZ2800A1/xx active
- 1999-05-25 TW TW088108576A patent/TW446696B/zh not_active IP Right Cessation
- 1999-05-31 EP EP99930059A patent/EP1084103B1/en not_active Expired - Lifetime
- 1999-05-31 EE EEP200000720A patent/EE04772B1/xx not_active IP Right Cessation
- 1999-05-31 SK SK1768-2000A patent/SK284642B6/sk not_active IP Right Cessation
- 1999-05-31 AT AT99930059T patent/ATE246674T1/de not_active IP Right Cessation
- 1999-05-31 CA CA002333938A patent/CA2333938C/en not_active Expired - Fee Related
- 1999-05-31 AU AU46671/99A patent/AU752261B2/en not_active Ceased
- 1999-05-31 NZ NZ508452A patent/NZ508452A/en unknown
- 1999-05-31 DK DK99930059T patent/DK1084103T3/da active
- 1999-05-31 WO PCT/SE1999/000941 patent/WO1999062872A1/en not_active Ceased
- 1999-05-31 ES ES99930059T patent/ES2205844T3/es not_active Expired - Lifetime
- 1999-05-31 PL PL99345205A patent/PL195189B1/pl not_active IP Right Cessation
- 1999-05-31 HU HU0103376A patent/HUP0103376A3/hu unknown
- 1999-05-31 CN CNB2005100687433A patent/CN1310881C/zh not_active Expired - Fee Related
- 1999-05-31 RU RU2000130189/04A patent/RU2214999C2/ru not_active IP Right Cessation
- 1999-05-31 IL IL13963699A patent/IL139636A/xx not_active IP Right Cessation
- 1999-05-31 US US09/341,904 patent/US6258850B1/en not_active Expired - Fee Related
- 1999-05-31 TR TR2000/03581T patent/TR200003581T2/xx unknown
- 1999-05-31 CZ CZ20004484A patent/CZ297424B6/cs not_active IP Right Cessation
- 1999-05-31 RS YUP-745/00A patent/RS49688B/sr unknown
- 1999-05-31 KR KR1020007013662A patent/KR100625152B1/ko not_active Expired - Fee Related
- 1999-05-31 CN CN99809340A patent/CN1311772A/zh active Pending
- 1999-05-31 PT PT99930059T patent/PT1084103E/pt unknown
- 1999-05-31 HR HR20000782A patent/HRP20000782B1/xx not_active IP Right Cessation
- 1999-05-31 JP JP2000552085A patent/JP3554539B2/ja not_active Expired - Fee Related
- 1999-05-31 UA UA2000116621A patent/UA71912C2/uk unknown
- 1999-05-31 ID IDW20002652A patent/ID28833A/id unknown
- 1999-05-31 DE DE69910203T patent/DE69910203T2/de not_active Expired - Fee Related
- 1999-05-31 BR BR9910928-0A patent/BR9910928A/pt not_active Application Discontinuation
- 1999-06-02 TN TNTNSN99108A patent/TNSN99108A1/fr unknown
- 1999-06-02 MY MYPI99002209A patent/MY117785A/en unknown
- 1999-06-03 AR ARP990102635A patent/AR020875A1/es active IP Right Grant
- 1999-06-03 EG EG65699A patent/EG24140A/xx active
- 1999-06-28 SA SA99200304A patent/SA99200304B1/ar unknown
-
2000
- 2000-05-22 AR ARP000102487A patent/AR024061A2/es unknown
- 2000-11-17 IS IS5714A patent/IS2071B/is unknown
- 2000-11-20 ZA ZA200006774A patent/ZA200006774B/en unknown
- 2000-12-01 NO NO20006115A patent/NO323426B1/no unknown
-
2001
- 2001-05-18 US US09/861,163 patent/US20010034371A1/en not_active Abandoned
-
2002
- 2002-01-04 US US10/039,868 patent/US6660879B2/en not_active Expired - Fee Related
-
2003
- 2003-07-11 JP JP2003273428A patent/JP2004043480A/ja not_active Withdrawn
- 2003-09-22 US US10/669,131 patent/US20040229946A1/en not_active Abandoned
-
2005
- 2005-03-11 US US11/078,201 patent/US20060040979A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002516900A5 (https=) | ||
| RU2000130189A (ru) | Новое производное i 3-арил-2-гидроксипропионовой кислоты | |
| EP0668851B1 (en) | A novel arylpropionic derivative, a process for the preparation and the use thereof as an analgesic agent | |
| JP2002508375A5 (https=) | ||
| CA2432121A1 (en) | Nitric oxide synthase inhibitor phosphate salt | |
| JP2002513793A5 (https=) | ||
| JP6215399B2 (ja) | ナルトレキソンの製造方法 | |
| JP2009161544A (ja) | チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用 | |
| JPH0681723B2 (ja) | 非−白金抗癌薬によりひき起こされる嘔吐の軽減用治療剤 | |
| JP2005513014A5 (https=) | ||
| US6939856B2 (en) | Method for preparing dexchlor tannate | |
| JP2004534802A (ja) | 重水素化Ｎ−及びα−置換ジフェニルアルコキシ酢酸アミノアルキルエステル並びにこれを含有する医薬品 | |
| MXPA01010822A (es) | Composicion farmaceutica novedosa. | |
| CA1172170A (en) | Antiviral alpha, alpha-dialkyl adamantylethylamines | |
| US6329407B1 (en) | Use of polycyclic thiazole systems for the treatment of obesity | |
| RU2005109560A (ru) | Фармацевтическая композиция, включающая кристаллический полугидрат метансульфоната сибутрамина | |
| JPH0725724B2 (ja) | トラネキサム酸亜鉛化合物 | |
| KR100601244B1 (ko) | 티아졸리딘디온 유도체 및 그의 당뇨병약으로서의 용도 | |
| RU2007143025A (ru) | Полиморфизм додекагидроклопента[а]фенантренилового эфира тиофенкарбоновой кислоты | |
| JP2003519683A5 (https=) | ||
| US6096760A (en) | Solid α-phenyl-2-piperidine acetate free base, its preparation and use in medicine | |
| JP2004532265A5 (https=) | ||
| JP2003520835A5 (https=) | ||
| CN1080851A (zh) | 生长激素释放抑制因子的增强剂 | |
| JPH0225468A (ja) | イミダゾール誘導体及びその製造方法 |